8 unchanged sentences
Gonzalez 69 Chairman of the Board and Chief Executive Officer
−Removed: Michael 51 Vice Chairman, Finance and Commercial Operations and Chief Financial Officer
−Removed: Schumacher 58 Vice Chairman, External Affairs and Chief Legal Officer
−Removed: Severino, M.D.
−Removed: 56 Vice Chairman and President
−Removed: Gosebruch 49 Executive Vice President, Chief Strategy Officer
+Added: Michael 52 Vice Chairman and President
+Added: Reents 55 Executive Vice President, Chief Financial Officer
Richmond 56 Executive Vice President, Chief Human Resources Officer
1 unchanged sentence
59 Executive Vice President, Operations
+Added: Siatis 48 Executive Vice President, General Counsel and Secretary
Stewart 54 Executive Vice President, Chief Commercial Officer
61 Senior Vice President, Research & Development and Chief Scientific Officer
−Removed: Sorg 55 Senior Vice President, U.S.
+Added: Sorg 56 Senior Vice President, AbbVie and President, U.S.
Commercial Operations
7 unchanged sentences
He was first appointed as an AbbVie corporate officer in December 2012.
−Removed: Michael is AbbVie’s Vice Chairman, Finance and Commercial Operations and Chief Financial Officer.
−Removed: Michael previously served as Executive Vice President, Chief Financial Officer from 2019 to 2021, as Senior Vice President, Chief Financial Officer from 2018 to 2019, and as Vice President, Controller from 2017 to 2018.
+Added: Michael is AbbVie’s Vice Chairman and President.
+Added: Michael previously served as Vice Chairman, Finance and Commercial Operations and Chief Financial Officer from June 2021 to June 2022, as Executive Vice President, Chief Financial Officer from 2019 to 2021, as Senior Vice President, Chief Financial Officer from 2018 to 2019 and as Vice President, Controller from 2017 to 2018.
He served as AbbVie’s Vice President, Treasurer from 2015 to 2016, as Vice President, Controller, Commercial Operations from 2013 to 2015 and Vice President, Financial Planning and Analysis from 2012 to 2013.
1 unchanged sentence
Michael served as Division Controller, Nutrition Supply Chain from 2010 to 2012.
−Removed: Michael joined Abbott in 1993 and was first appointed as an AbbVie corporate officer in December 2015.
−Removed: Schumacher is AbbVie’s Vice Chairman, External Affairs and Chief Legal Officer, responsible for global legal, health economics outcomes research, corporate responsibility, brand and communications and government affairs.
−Removed: Prior to her current appointment in 2018, she served as AbbVie’s Executive Vice President, External Affairs, General Counsel and Corporate Secretary.
−Removed: Prior to AbbVie’s separation from Abbott, Ms.
−Removed: Schumacher served as Executive Vice President, General Counsel from 2007 to 2012.
−Removed: Both at Abbott and AbbVie, Ms.
−Removed: Schumacher also led Business Development and Ventures and Early Stage Collaborations.
−Removed: Schumacher was first appointed as an AbbVie corporate officer in December 2012.
−Removed: She serves on the board of General Dynamics Corporation and CrowdStrike Holdings, Inc.
−Removed: Severino is AbbVie’s Vice Chairman and President, responsible for research and development and the corporate strategy office.
−Removed: He served as Executive Vice President, Research and Development and Chief Scientific Officer from 2014 to 2018.
−Removed: Severino served at Amgen Inc.
−Removed: as Senior Vice President, Global Development and Corporate Chief Medical Officer from 2012 to 2014, as Vice President, Global Development from 2010 to 2012 and as Vice President, Therapeutic Area Head, General Medicine and Inflammation Global Clinical Development from 2007 to 2012.
−Removed: He joined AbbVie in 2014 and was first appointed as an AbbVie corporate officer in June 2014.
−Removed: Severino also serves on the board of Avantor, Inc.
−Removed: Gosebruch is AbbVie's Executive Vice President, Chief Strategy Officer.
−Removed: He worked for more than 20 years in the Mergers & Acquisitions Group at J.P.
−Removed: Morgan Securities LLC, serving as Managing Director since 2007 and as Co-Head of M&A North America during 2015.
−Removed: Gosebruch joined AbbVie in 2015 and was first appointed as an AbbVie corporate officer in December 2015.
−Removed: He serves on the board of Aptinyx Inc.
+Added: Michael joined Abbott in 1993 and was first appointed as an AbbVie corporate officer in March 2017.
+Added: Reents is AbbVie’s Executive Vice President, Chief Financial Officer.
+Added: He previously served as Senior Vice President, Chief Financial Officer from June 2022 to November 2022, as Vice President, Tax and Treasury from 2019 to June 2022, and as Vice President, Tax from 2013 to 2019.
+Added: Reents joined Abbott in 2008 and was first appointed as an AbbVie corporate officer in June 2022.
Richmond is AbbVie’s Executive Vice President, Chief Human Resources Officer.
He served as Senior Vice President, Human Resources from 2013 to 2018.
−Removed: Richmond served as Abbott’s Divisional Vice President of Compensation & Benefits from 2008 to 2012, as Group Vice President of Talent and Rewards from 2007 to 2008, and as Divisional Vice President of
−Removed: | 2021 Form 10-K
−Removed: Talent Acquisition from 2006 to 2007.
+Added: Richmond served as Abbott’s Divisional Vice President of Compensation & Benefits from 2008 to 2012, as Group Vice President of Talent and Rewards from 2007 to 2008 and as Divisional Vice President of Talent Acquisition from 2006 to 2007.
Richmond joined Abbott in 2006 and was first appointed as an AbbVie corporate officer in December 2012.
4 unchanged sentences
She serves on the board of Entegris Inc.
+Added: Siatis is AbbVie’s Executive Vice President, General Counsel and Secretary.
+Added: Siatis previously served as Senior Vice President, Deputy General Counsel from September 2021 until October 2022.
+Added: From 2013 until 2021, Mr.
+Added: Siatis also served in various roles including as Senior Vice President, Legal and Chief Ethics and Compliance Officer;
+Added: Senior Vice President of Legal Transactions and R&D/Alliance Management and Chief Ethics and Compliance Officer;
+Added: and Vice President, Biologic Strategic Development and Legal Regulatory.
+Added: Siatis joined Abbott in 2005 and was first appointed as an AbbVie corporate officer in October 2022.
Stewart is AbbVie’s Executive Vice President, Chief Commercial Officer.
1 unchanged sentence
Commercial Operations from 2018 to 2020 and as AbbVie’s President, Commercial Operations from 2013 to
+Added: | 2022 Form 10-K
Prior to AbbVie’s separation from Abbott, he served as Vice President, Abbott Proprietary Pharmaceutical Division, United States.
6 unchanged sentences
Hudson was first appointed as an AbbVie corporate officer in July 2019.
−Removed: Sorg is AbbVie’s Senior Vice President, U.S.
+Added: Sorg is AbbVie’s Senior Vice President, AbbVie, and President U.S.
Commercial Operations.
22 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.